Global Cell Therapy Processing Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2017 – 2025

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Cell Therapy Processing Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Cell Therapy Processing Market by Offering Type: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Products

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Services

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Software

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Cell Therapy Processing Market by Application: Market Size and Forecast, 2019 – 2028 

5.1  Overview

5.2  Cardiovascular Offering Type

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Bone Repair

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Neurological Disorders

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.5  Skeletal Muscle Repair Immune Offering Types

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Cell Therapy Processing Market by Geography: Market Size and Forecast, 2019 - 2028

6.1  Overview

6.1.1   Global Cell Therapy Processing Market Year-on-Year Growth, by region 2020 – 2028 (%)

6.2  North America

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   U.S.

6.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3.2        By Offering Type

6.2.3.3        By Application

6.2.4   Canada

6.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.4.2        By Offering Type

6.2.4.3        By Application

6.2.5   Mexico

6.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.5.2        By Offering Type

6.2.5.3        By Application

6.3    Europe

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3   UK

6.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3.2        By Offering Type

6.3.3.3        By Application

6.3.4   Russia

6.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.4.2        By Offering Type

6.3.4.3        By Application

6.3.5   France

6.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.5.2        By Offering Type

6.3.5.3        By Application

6.3.6   Italy

6.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.6.2        By Offering Type

6.3.6.3        By Application

6.3.7   Germany

6.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.7.2        By Offering Type

6.3.7.3        By Application

6.3.8   Rest of Europe

6.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.8.2        By Offering Type

6.3.8.3        By Application

6.4    Asia-Pacific

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3   China

6.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3.2        By Offering Type

6.4.3.3        By Application

6.4.4   India

6.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.4.2        By Offering Type

6.4.4.3        By Application

6.4.5   Japan

6.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.5.2        By Offering Type

6.4.5.3        By Application

6.4.6   Rest of Asia-Pacific

6.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.6.2        By Offering Type

6.4.6.3        By Application

6.5    RoW

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast

6.5.3   South America

6.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.3.2        By Offering Type

6.5.3.3        By Application

6.5.4   Middle East

6.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.4.2        By Offering Type

6.5.4.3        By Application

6.5.5   Africa

6.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.5.2        By Offering Type

6.5.5.3        By Application

Chapter 7        Company Profiles

7.1  Biotime Inc.

7.1.1     Company Overview

7.1.2     Product Portfolio

7.1.3     Business Strategies

7.1.4     Financials

7.1.5     Recent Developments

7.2  Bone Therapeutics SA

7.2.1     Company Overview

7.2.2     Product Portfolio

7.2.3     Business Strategies

7.2.4     Financials

7.2.5     Recent Developments

7.3  Caladrius Biosciences

7.3.1     Company Overview

7.3.2     Product Portfolio

7.3.3     Business Strategies

7.3.4     Financials

7.3.5     Recent Developments

7.4  Cell Biomed Group

7.4.1     Company Overview

7.4.2     Product Portfolio

7.4.3     Business Strategies

7.4.4     Financials

7.4.5     Recent Developments

7.5  Cell Design Labs

7.5.1     Company Overview

7.5.2     Product Portfolio

7.5.3     Business Strategies

7.5.4     Financials

7.5.5     Recent Developments

7.6  Cell Therapies PTY Ltd.

7.6.1     Company Overview

7.6.2     Product Portfolio

7.6.3     Business Strategies

7.6.4     Financials

7.6.5     Recent Developments

7.7  Flodesign Sonics

7.7.1     Company Overview

7.7.2     Product Portfolio

7.7.3     Business Strategies

7.7.4     Financials

7.7.5     Recent Developments

7.8  Invitrx Therapeutics Inc.

7.8.1     Company Overview

7.8.2     Product Portfolio

7.8.3     Business Strategies

7.8.4     Financials

7.8.5     Recent Developments

7.9  Iovance Biotherapeutics Inc.

7.9.1     Company Overview

7.9.2     Product Portfolio

7.9.3     Business Strategies

7.9.4     Financials

7.9.5     Recent Developments

7.10       Nantworks LLC

7.10.1   Company Overview

7.10.2   Product Portfolio

7.10.3   Business Strategies

7.10.4   Financials

7.10.5   Recent Developments

7.11       Novartis

7.11.1   Company Overview

7.11.2   Product Portfolio

7.11.3   Business Strategies

7.11.4   Financials

7.11.5   Recent Developments

7.12       Plasticell Ltd.

7.12.1   Company Overview

7.12.2   Product Portfolio

7.12.3   Business Strategies

7.12.4   Financials

7.12.5   Recent Developments

7.13       Regeneus Ltd.

7.13.1   Company Overview

7.13.2   Product Portfolio

7.13.3   Business Strategies

7.13.4   Financials

7.13.5   Recent Developments

7.14       Regen Biopharma Inc.

7.14.1   Company Overview

7.14.2   Product Portfolio

7.14.3   Business Strategies

7.14.4   Financials

7.14.5   Recent Developments

7.15       Sanbio Co. Ltd.

7.15.1   Company Overview

7.15.2   Product Portfolio

7.15.3   Business Strategies

7.15.4   Financials

7.15.5   Recent Developments

7.16       Sartorius Stedim Biotech

7.16.1   Company Overview

7.16.2   Product Portfolio

7.16.3   Business Strategies

7.16.4   Financials

7.16.5   Recent Developments

7.17       Stemgenex Medical Group

7.17.1   Company Overview

7.17.2   Product Portfolio

7.17.3   Business Strategies

7.17.4   Financials

7.17.5   Recent Developments

7.18       Targazyme Inc.

7.18.1   Company Overview

7.18.2   Product Portfolio

7.18.3   Business Strategies

7.18.4   Financials

7.18.5   Recent Developments

7.19       Tosoh Corp.

7.19.1   Company Overview

7.19.2   Back to top

Payment Options

Single User $3897
Five User $5175
Enterprise $9175
Datapack $1299
Short Report: $1799